Advancing science and education through a novel collaboration platform between the University of Michigan and Peking University Health Science Center

期刊： FASEB BIOADVANCES, 2021; 3 (6)

Research in China has been advancing over the past decade with increasing investments from government and private entities. Collaboration with Chinese......

Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib-resistance

期刊： FASEB BIOADVANCES, 2021; 3 (6)

Vismodegib, a Smoothened antagonist, is clinically approved for treatment of human basal cell carcinoma (BCC), in the clinical trials of medulloblasto......

High nerve density in breast cancer is associated with poor patient outcome

期刊： FASEB BIOADVANCES, 2022; 4 (6)

Active crosstalk between the nervous system and breast cancer cells has been experimentally demonstrated in vitro and in animal models. However, low f......

Elevated serum Cripto-1 and VEGF levels in patients with non-small cell lung cancer

期刊： FASEB BIOADVANCES, 2022; 4 (8)

Cripto-1 (CR-1) facilitates vascular endothelial growth factor (VEGF) expression, and these markers are associated with various tumor cell proliferati......

Impact of a long-term high-fructose diet on systemic metabolic profiles of mice

期刊： FASEB BIOADVANCES, 2022; 4 (8)

Evidence is mounting that chronic high-fructose diets (HFrD) can lead to metabolic abnormalities and cause a variety of diseases. However, the underly......

A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients

期刊： FASEB BIOADVANCES, 2022; 4 (9)

Colon adenocarcinoma (COAD) has a high incidence and death rate. Despite the fact that change in fatty acid metabolism promotes tumor growth and metas......